Erdafitinib in Urothelial Carcinoma. Reply
N Engl J Med
.
2019 Oct 17;381(16):1594-1595.
doi: 10.1056/NEJMc1911187.
Authors
Yohann Loriot
1
,
Andrea Necchi
2
,
Arlene O Siefker-Radtke
3
Affiliations
1
Gustave Roussy, Villejuif, France.
2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
3
University of Texas M.D. Anderson Cancer Center, Houston, TX asiefker@mdanderson.org.
PMID:
31618553
DOI:
10.1056/NEJMc1911187
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Transitional Cell*
Humans
Protein Kinase Inhibitors
Urologic Neoplasms*
Substances
Protein Kinase Inhibitors